Universal Legal advises Advy Biosciences on DiabetOmics Medical acquisition

• Advy Biosciences has acquired DiabetOmics Medical Private Limited and rebranded it as Advy BioLucent Private Limited.
• Universal Legal advised Advy Biosciences on the acquisition, led by Rashi Kapoor Mehta and Neelkamal Chaudhary.
• The acquisition includes a state-of-the-art manufacturing facility in Medak, near Hyderabad, strengthening Advy's medical device production and CDMO partnerships.

This strategic acquisition has enabled Advy to secure a cutting-edge manufacturing facility in Medak, near Hyderabad.

Advy Biosciences has made a significant move in the medical device industry with the acquisition of DiabetOmics Medical Private Limited, now rebranded as Advy BioLucent Private Limited. The transaction was guided by Universal Legal's team, led by Rashi Kapoor Mehta (Partner) and Neelkamal Chaudhary (Associate Partner). Additionally, Neha Sehgal (Partner) and Angshuman Chaliha (Associate Partner) provided support on real estate aspects. This strategic acquisition has enabled Advy to secure a cutting-edge manufacturing facility in Medak, near Hyderabad.

The acquisition highlights the growing importance of partnerships and collaborations in the medical device industry. As companies like Advy Biosciences expand their capabilities through strategic acquisitions, they must navigate complex regulatory landscapes to ensure compliance with Indian laws and regulations. The transfer of ownership and operation of manufacturing facilities raises questions about manufacturing facility ownership and CDMO agreements, which lawyers advising clients on medical device partnerships should carefully consider.

This acquisition has significant implications for the medical device industry in India. With Advy Biosciences now owning a state-of-the-art manufacturing facility, it can strengthen its position as a leading player in medical device production and CDMO partnerships. Furthermore, this deal demonstrates Universal Legal's expertise in advising clients on complex transactions and navigating regulatory requirements. As the Indian M&A market continues to grow, companies like Advy Biosciences will need to carefully consider their strategies for growth and expansion.

Lawyers advising clients on medical device partnerships should watch for the implications of this acquisition, particularly regarding manufacturing facility ownership and CDMO agreements.

Source: Original reporting via Universal Legal